Your browser doesn't support javascript.
loading
The Long Pentraxin 3 Plays a Role in Bone Turnover and Repair.
Grcevic, Danka; Sironi, Marina; Valentino, Sonia; Deban, Livija; Cvija, Hrvoje; Inforzato, Antonio; Kovacic, Natasa; Katavic, Vedran; Kelava, Tomislav; Kalajzic, Ivo; Mantovani, Alberto; Bottazzi, Barbara.
Affiliation
  • Grcevic D; Department of Physiology and Immunology, University of Zagreb School of Medicine, Zagreb, Croatia.
  • Sironi M; Croatian Institute for Brain Research, University of Zagreb School of Medicine, Zagreb, Croatia.
  • Valentino S; Humanitas Clinical and Research Center, Milan, Italy.
  • Deban L; Humanitas Clinical and Research Center, Milan, Italy.
  • Cvija H; Humanitas Clinical and Research Center, Milan, Italy.
  • Inforzato A; Oxford BioTherapeutics Ltd., Abingdon, United Kingdom.
  • Kovacic N; Department of Physiology and Immunology, University of Zagreb School of Medicine, Zagreb, Croatia.
  • Katavic V; Croatian Institute for Brain Research, University of Zagreb School of Medicine, Zagreb, Croatia.
  • Kelava T; Humanitas Clinical and Research Center, Milan, Italy.
  • Kalajzic I; Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy.
  • Mantovani A; Croatian Institute for Brain Research, University of Zagreb School of Medicine, Zagreb, Croatia.
  • Bottazzi B; Department of Anatomy, University of Zagreb School of Medicine, Zagreb, Croatia.
Front Immunol ; 9: 417, 2018.
Article in En | MEDLINE | ID: mdl-29556234
ABSTRACT
Pentraxin 3 (PTX3) is an inflammatory mediator acting as a fluid-phase pattern recognition molecule and playing an essential role in innate immunity and matrix remodeling. Inflammatory mediators also contribute to skeletal homeostasis, operating at multiple levels in physiological and pathological conditions. This study was designed to investigate the role of PTX3 in physiological skeletal remodeling and bone healing. Micro-computed tomography (µCT) and bone histomorphometry of distal femur showed that PTX3 gene-targeted female and male mice (ptx3-/- ) had lower trabecular bone volume than their wild-type (ptx3+/+ ) littermates (BV/TV by µCT 3.50 ± 1.31 vs 6.09 ± 1.17 for females, p < 0.0001; BV/TV 9.06 ± 1.89 vs 10.47 ± 1.97 for males, p = 0.0435). In addition, µCT revealed lower trabecular bone volume in second lumbar vertebra of ptx3-/- mice. PTX3 was increasingly expressed during osteoblast maturation in vitro and was able to reverse the negative effect of fibroblast growth factor 2 (FGF2) on osteoblast differentiation. This effect was specific for the N-terminal domain of PTX3 that contains the FGF2-binding site. By using the closed transversal tibial fracture model, we found that ptx3-/- female mice formed significantly less mineralized callus during the anabolic phase following fracture injury compared to ptx3+/+ mice (BV/TV 17.05 ± 4.59 vs 20.47 ± 3.32, p = 0.0195). Non-hematopoietic periosteal cells highly upregulated PTX3 expression during the initial phase of fracture healing, particularly CD51+ and αSma+ osteoprogenitor subsets, and callus tissue exhibited concomitant expression of PTX3 and FGF2 around the fracture site. Thus, PTX3 supports maintenance of the bone mass possibly by inhibiting FGF2 and its negative impact on bone formation. Moreover, PTX3 enables timely occurring sequence of callus mineralization after bone fracture injury. These results indicate that PTX3 plays an important role in bone homeostasis and in proper matrix mineralization during fracture repair, a reflection of the function of this molecule in tissue homeostasis and repair.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Osteoblasts / C-Reactive Protein / Serum Amyloid P-Component / Fractures, Bone Type of study: Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: Front Immunol Year: 2018 Type: Article Affiliation country: Croatia

Full text: 1 Database: MEDLINE Main subject: Osteoblasts / C-Reactive Protein / Serum Amyloid P-Component / Fractures, Bone Type of study: Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: Front Immunol Year: 2018 Type: Article Affiliation country: Croatia